Let's Talk Innovation

Let's Talk
Innovation

You are here

Biocartis Raises €64.5 Million

London
Innovation Center September 4th, 2014

New technologies in the form of sophisticated molecular diagnostic tools are needed to advance the era of personalized medicine –the customization of healthcare based on molecular analysis so that clinical decisions and products can be tailored to the individual patient.

As part of our interest in advance these promising technologies, Johnson & Johnson Development Corporation has been a strategic investor in Biocartis since 2010.  Biocartis is a Belgium-based company developing molecular diagnostic tools to be used in a variety of healthcare settings.  Our colleagues at Janssen Diagnostics have a longstanding collaboration with the company to develop their platform in the areas of neuroscience and certain infectious / viral diseases.

Today we are happy to be participating in a new round of fundraising that will be used to support the commercial launch of Biocartis’ Idylla™ system.  

The Idylla platform is a point-of-care diagnostic tool designed to detect and quantify multiple DNA or RNA-based biomarkers in a variety of patient sample types.  Our collaboration around this platform is in keeping with Janssen Diagnostics interest in improving outcomes for patients through the use of technologies that make clinical information available to healthcare providers and patients to make better informed treatment decisions.

We believe innovation in healthcare is fundamentally about advances that make a difference to patient care whether these advances come in the form of new medicines, new medical devices, or new technologies that support clinical decision making.  It is our privilege to work with companies and entrepreneurs around the world who share our commitment to improve patient care.

 

Add new comment

Leave a comment

You agree that the information you provide will be governed by our Privacy Policy.
Your email address and last name will not be displayed publicly with your comment.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 10 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

We reserve the right to not post any comment that is considered inappropriate, off-topic, abusive, or that is used to promote and solicit for third party sites, initiatives, or products. All comments will be reviewed and may not be posted if deemed inappropriate. Approved comments may take up to 72 hours after they are received to be posted.

This Blog is not intended to be a place to report customer service, adverse events or product quality complaints. We take adverse events and product quality complaints very seriously. To report an adverse event or product quality complaint, please send us a message at jnjinnovation@its.jnj.com.